Cargando…
Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections
Repurposing drugs provides a new approach to the fight against multidrug-resistant (MDR) bacteria. We have reported that three major tamoxifen metabolites, N-desmethyltamoxifen (DTAM), 4-hydroxytamoxifen (HTAM), and endoxifen (ENDX), presented bactericidal activity against Acinetobacter baumannii an...
Autores principales: | Miró-Canturri, Andrea, Vila-Domínguez, Andrea, Caretero-Ledesma, Marta, Ayerbe-Algaba, Rafael, Pachón, Jerónimo, Jiménez-Mejías, Manuel Enrique, Smani, Younes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528103/ https://www.ncbi.nlm.nih.gov/pubmed/34668743 http://dx.doi.org/10.1128/Spectrum.00403-21 |
Ejemplares similares
-
Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021) -
Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021) -
Drug Repurposing for the Treatment of Bacterial and Fungal Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2019) -
Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2022) -
Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models
por: Miró-Canturri, Andrea, et al.
Publicado: (2021)